Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Eric AJ Hoste, Sean M Bagshaw, Rinaldo Bellomo, Cynthia M Cely, Roos Colman, Dinna N Cruz, Kyriakos Edipidis, Lui G Forni, Charles D Gomersall, Deepak Govil, Patrick M Honore, Olivier Joannes-Boyau, Michael Joannidis, Anna-Maija Korhonen, Athina Lavrentieva, Ravindra L Mehta, Paul Palevsky, Eric Roessler, Claudio Ronco, Shigehiko Uchino Show all
Intensive Care Medicine | SPRINGER | Published : 2015
EH received speakers fee from Astute Medical, and an Industrial Research Fund (IOF) from Ghent University for a validation study on a biomarker for AKI. SMB has consulted for and received honoraria from Gambro-Baxter. CG has received sponsorship for an academic conference from Gambro. OJB has received grants and non-financial support from Gambro, BBraun, Fresenius, and Astute Medical. MJ has consulted for and received honoraria from Baxter, Gambro, Fresenius, CLS Behring, BBraun, AM Pharma, Sanofi, Astute. JK has received grant support and/or consulting fees from Fresenius, Gambro, Baxter, Astute Medical, Alere, AM Pharma, Spectral, Grifols, Cytosorbents, Alung, Atox Bio, Bard, Kaneka. RM has received grants from the International Safety Adverse Events Consortium and Thrasos, he has options in Astute Medical and served in the scientific advisory board for trials for Abbvie, AM Pharma, and Eli Lilly, and consulted for CSL Behring, GSK, Baxter, Sova, Astellas, and Sanofi-Aventis. PP has consulted for Complexa Inc. SW is Director and Shareholder of Aalix Healthcare Services Consulting, which has provided services related to AKI.